Latest Breaking News On - Clemente drive - Page 7 : comparemela.com

Tenax Therapeutics Announces Pricing of Approximately $9 Million Public Offering

Tenax Therapeutics Announces Pricing of Approximately $9 Million Public Offering
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesJohn frauncesBrian mullenExchange commissionOrion corporationLifesci advisorsRoth capital partnersTenax therapeutics incNasdaq stock marketTherapeutics announces pricingCommon warrantsCapital partnersClemente driveNewport beachNorth americanTenax therapeutic phase

Tenax Therapeutics Announces Pricing of Approximately $9

CHAPEL HILL, N.C., Feb. 08, 2024 (GLOBE NEWSWIRE) Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying,.

United statesJohn frauncesBrian mullenTenax therapeutics incNasdaq stock marketExchange commissionLifesci advisorsOrion corporationRoth capital partnersCommon warrantsCapital partnersClemente driveNewport beachNorth americanTenax therapeutic phaseTenax therapeutic

Tenax Therapeutics (TENX) Prices 1 6M Share Offering at $5 65/sh

Tenax Therapeutics (TENX) Prices 1 6M Share Offering at $5 65/sh
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Exchange commissionTenax therapeutics incRoth capital partnersTenax therapeuticsCommon warrantsCapital partnersClemente driveNewport beach

Revelation Biosciences Inc Announces Closing of $6 2 Million Public Offering

SAN DIEGO (BUSINESS WIRE) #biotechnews Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, today announced the closing on February 5, 2024 of its previously anno.

Sandra vedrickRevelation biosciences incExchange commissionCompany or revelationRoth capital partnersRevelation biosciencesCapital partnersClemente driveNewport beachPrivate securities litigation reform actInvestor relations

Revelation Biosciences Inc Announces Pricing of $6 2 Million Public Offering

Revelation Biosciences Inc. , a life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, today announced the pricing of a public.

Revelation biosciences incCompany or revelationRoth capital partnersExchange commissionRevelation biosciencesCapital partnersClemente driveNewport beachPrivate securities litigation reform act